Concomitant Active Tuberculosis Prolongs Survival in Non-Small Cell Lung Cancer: A Study in a Tuberculosis-Endemic Country

BACKGROUND: Adjuvant tumor cell vaccine with chemotherapy against non-small cell lung cancer (NSCLC) shows limited clinical response. Whether it provokes effective cellular immunity in tumor microenvironment is questionable. Concomitant active tuberculosis in NSCLC (TBLC) resembles locoregional immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Chih-Hsi, Lo, Chun-Yu, Chung, Fu-Tsai, Lee, Kang-Yun, Lin, Shu-Min, Wang, Chun-Hua, Heh, Chih-Chen, Chen, Hao-Cheng, Kuo, Han-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306389/
https://www.ncbi.nlm.nih.gov/pubmed/22438899
http://dx.doi.org/10.1371/journal.pone.0033226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306389/
https://www.ncbi.nlm.nih.gov/pubmed/22438899
http://dx.doi.org/10.1371/journal.pone.0033226

Ejemplares similares